John H. Conway

John H. Conway has a diverse work experience in the field of medicinal chemistry. John H. began their career as an Intern at Sanofi Genzyme in 2009. After completing their internship, they pursued a PhD at Princeton University where they served as a Graduate Student from 2010 to 2015. Following their PhD, John held positions as a Postdoctoral Research Assistant at Colorado State University from 2015 to 2016, and as a Postdoctoral Research Associate at Columbia University in the City of New York from 2016 to 2017. John H. then transitioned to industry, working at Gilead Sciences as a Scientist in Medicinal Chemistry from 2018 to 2021. In 2021, they joined Syros Pharmaceuticals as a Scientist II in Medicinal Chemistry and remained there until 2022. Currently, they hold the position of Scientist II in Medicinal Chemistry at Frontier Medicines, starting in 2022.

John H. Conway completed their education at three different institutions. John H. first attended Boston College from 2006 to 2010, where they earned a Bachelor's degree in Chemistry. John H. then pursued further education at Princeton University, starting in 2010. At Princeton, they first obtained a Master of Arts (M.A.) in Chemistry in 2011. Subsequently, they continued their studies and completed a Doctor of Philosophy (PhD) in Chemistry at Princeton University from 2010 to 2015.